Delivery Order SPE2DB22D2211-SPE2DB25FRUWV
Award Date
4/8/25
Potential Completion Date
4/29/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,704.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,059,457 units of the prescription medication BOSULIF 100 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the supply of BOSULIF 100 MG TABLET 120S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,334.07, is for the delivery of BOSULIF 400 MG TABLET 30S. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a $5,523.71 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 120 tablets of the drug Bosulif 100 mg. This contract has a completion date of February 7, 2025 and was awarded on January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a range of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,288.86, is a delivery order for the supply of BOSULIF 500 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product, with a performance period through December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order contract is for the supply of BOSULIF 400 MG TABLET 30S, a prescription drug, with a period of performance through March 18, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bosulif 400 mg tablets. The $23,631.26 firm-fixed-price contract has a completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of BOSULIF 500 MG TABLET 30S, a pharmaceutical product. The firm-fixed-price Delivery Order, valued at $10,577.74, has a period of performance through November 25, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...